La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Moleculin Biotech a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Moleculin Biotech..

Moleculin Biotech (NASDAQ:MBRX) Azioni, Catena delle Opzioni

Moleculin Biotech

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) predicted Air Jordan would make only $3 million in sales over its first three to four years. Instead, the line <a href="https://www.inc.com/jeff-haden/how-much-has-michael-jordan-been-paid-for-his-nike-jordan-brand-partnership-not-nearly-enough.html">brought in about $126 million</a> in its first year. That breakout success vaulted NBA great Michael Jordan into retail legend and reshaped Nike's future.
Jordan Brand now earns billions yearly, keeping the Jumpman logo central to modern sneaker culture. That journey started with one risky contract and a shoe the NBA tried to ban.
<h2 class="wp-block-heading">Rookie Deal Reshapes Sneakers</h2>
In October 1984, after meeting at Nike's headquarters in Beaverton, Oregon, <a href="https://www.espn.com/blog/playbook/dollars/post/_/id/2918/how-nike-landed-michael-jordan?">Nike signed</a> Jordan to a five-year endorsement deal worth $500,000 annually.
Don't Miss:
<ul class="wp-block-list">
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
"Nike&#8217;s expectation was at the end of year four they hoped to sell $3 million of Air Jordans," agent David Falk said in <a href="https://www.cbssports.com/nba/news/the-last-dance-story-behind-michael-jordan-nearly-choosing-adidas-over-nike-explained-in-doc/">ESPN's documentary</a>, "The Last Dance." Jordan had favored Adidas, yet his mother, Deloris, persuaded him to hear Nike's pitch.
The contract included a signature shoe, unheard of for a rookie, plus stock options and royalties on every pair sold. Nike backed the launch with posters, television spots, and campus tours that cast the 21-year-old guard as both hero and rebel. By season's end, Air Jordan revenue hit $126 million, smashing every forecast and proving a player could anchor an entire product family.
<h2 class="wp-block-heading">Banned Shoe Fuels Buzz</h2>
"The NBA threw them out of the game. Fortunately, the NBA can't keep you from wearing them," teased a <a href="https://www.youtube.com/watch?v=f5QbV-wnhtY">Nike ad</a> after the league cited uniform rules and fined Jordan $5,000 each game for wearing the red-and-black Air Jordan 1, which debuted on April 1, 1985.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
The controversy sparked demand. <a href="https://www.espn.com/espn/sportsbusiness/news/story?id=1920101">Retailers moved</a> 450,000 pairs within a month at $65 each, ESPN added. Rappers, playground players, and director Spike Lee amplified the buzz, making the sneakers status symbols beyond sport.&nbsp;
Analysts later called the launch the first modern "drop," where scarcity and story fuel instant sell-outs. That momentum helped Nike secure future athlete lines, from Charles Barkley in 1992 to LeBron James in 2003, each modeled on Jordan's template.
<h2 class="wp-block-heading">Jumpman Revenue Soars</h2>
Jordan Brand became a standalone Nike division in 1997 and still powers earnings today. For the quarter that ended May. 31, Nike <a href="https://investors.nike.com/investors/news-events-and-reports/investor-news/investor-news-details/2025/NIKE-Inc--Reports-Fiscal-2025-Fourth-Quarter-and-Full-Year-Results/default.aspx">posted </a>$11.1 billion in revenue. Jordan Brand recorded $7.27 for the full fiscal year, following a 16% year-over-year decline.&nbsp;
<a href="https://www.forbes.com/sites/justinbirnbaum/2023/10/02/michael-jordan-joins-forbes-400-worth-3-billion/">Forbes</a> reported Jordan's net worth at about $3 billion, driven by royalties exceeding $150 million a year. Hype stays sharp.<a href="https://sneakernews.com/2025/04/23/travis-scott-jordan-jumpman-jack-bright-cactus-fz8117-102-release-date/"> Sneaker News</a> reported the Travis Scott x Jordan Jumpman Jack "Bright Cactus" sold out on April 30 at $200.<a href="https://www.gq.com/story/air-jordan-1-low-chicago-2025-release"> GQ</a> wrote that the Air Jordan 1 Low "Chicago" returns this holiday season for $140.&nbsp;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence. </a></li>
</ul>
Image: Shutterstock

News

Nike Expected $3 Million In Sales — Air Jordan Made $126 Million In Year One And Became A Global Icon

Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>) has outperformed the market over the past 15 years by 1.59% on an annualized basis producing an average annual return of 13.83%. Currently, Canadian Pacific Kansas has a market capitalization of $75.36 billion. 
Buying $100 In CP: If an investor had bought $100 of CP stock 15 years ago, it would be worth $706.37 today based on a price of $80.71 for CP at the time of writing.
<h3>Canadian Pacific Kansas's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752018312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Canadian Pacific Kansas 15 Years Ago Would Be Worth This Much Today

WIIM

COGT

COGT stock has given up its prior loss. Cogent Biosciences shares were trading lower after the company announced a proposed $150 million public offering of common stock.

Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) has outperformed the market over the past 20 years by 1.7% on an annualized basis producing an average annual return of 10.13%. Currently, Honeywell Intl has a market capitalization of $155.64 billion. 
Buying $1000 In HON: If an investor had bought $1000 of HON stock 20 years ago, it would be worth $6,880.36 today based on a price of $241.95 for HON at the time of writing.
<h3>Honeywell Intl's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752017414_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Honeywell Intl 20 Years Ago Would Be Worth This Much Today

Murphy USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUSA#NYSE">MUSA</a>) has outperformed the market over the past 5 years by 15.12% on an annualized basis producing an average annual return of 29.65%. Currently, Murphy USA has a market capitalization of $8.18 billion. 
Buying $1000 In MUSA: If an investor had bought $1000 of MUSA stock 5 years ago, it would be worth $3,603.84 today based on a price of $413.36 for MUSA at the time of writing.
<h3>Murphy USA's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752016511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MUSA

Here's How Much You Would Have Made Owning Murphy USA Stock In The Last 5 Years

Kevin &#8220;Mr. Wonderful&#8221; O&#8217;Leary, never one to back down from a challenge, finds himself in the thick of one of the most complex international business sagas in recent memory: the potential sale of TikTok&#8216;s <a href="https://www.benzinga.com/markets/tech/25/07/46267944/tiktok-to-roll-out-new-us-app-as-trump-says-we-pretty-much-have-a-deal-report">U.S. operations.&nbsp;</a>
The outspoken investor has publicly declared his intent to lead a syndicate to acquire the popular app, but as he laid out in a social media post on Monday, the path to a deal is a minefield of geopolitical and technical challenges.
Read Next: <a href="https://www.benzinga.com/news/politics/25/07/46308025/get-ready-for-800-hours-of-blackouts-trumps-doe-warns?utm_source=articleShare">Get Ready For 800 Hours Of Blackouts, Trump&#8217;s DOE Warns</a>&nbsp;
The Details: O'Leary wrote in the post that the heart of the issue is the lack of a willing seller as any potential deal <a href="https://www.benzinga.com/news/social-media/25/07/46265991/donald-trump-announces-upcoming-talks-with-china-on-tiktok-we-pretty-much-have-a-deal">requires the approval </a>of both President Donald Trump and Chinese President Xi Jinping.&nbsp;
"We don&#8217;t have a seller yet. However the syndicate ends up, we don&#8217;t know. This is a complicated deal. Two factors to consider: Number one, we need Xi and Trump to agree they&#8217;re gonna be a buyer and a seller. That&#8217;s number one," O'Leary wrote.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We don&#39;t have a seller yet. However the syndicate ends up, we don&#39;t know. This is a complicated deal. Two factors to consider: Number one, we need Xi and Trump to agree they&#39;re gonna be a buyer and a seller. That&#39;s number one. Number two, we need to figure out a way to take care… <a href="https://t.co/cpQEQHvo66">pic.twitter.com/cpQEQHvo66</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1942277484541812957?ref_src=twsrc%5Etfw">July 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The second major obstacle is TikTok's algorithm itself, the investor said.&nbsp;
"Number two, we need to figure out a way to take care of Sen. Cotton&#8217;s concerns around the algorithm and many others who are not going to give an indemnification for using the original algorithm. We have to solve for that too," O'Leary wrote. 
U.S. Sen. Tom Cotton (R-Ark.) and other legislators have raised national security concerns, insisting that any sale must guarantee a complete separation from Chinese technology and influence. They fear the algorithm could be used for data harvesting or to push foreign propaganda to its 170 million American users. 
Despite these roadblocks, O&#8217;Leary remains characteristically confident.&nbsp;
&#8220;My bet, not to sound arrogant, is I will be there at the table at the end,&#8221; he wrote in the post.&nbsp;
The world will watch to see if Mr. Wonderful can navigate the intricate web of politics and technology to pull off this &#8220;legacy opportunity&#8221; deal.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46284237/sofi-ready-to-capture-the-opportunity-as-trumps-big-beautiful-plan-restricts-federal-student-loans?utm_source=articleShare">SoFi Ready To &#8216;Capture The Opportunity&#8217; As Trump&#8217;s &#8216;Big, Beautiful&#8217; Plan Restricts Federal Student Loans</a></li>
</ul>
Photo: Shutterstock

Social Media

Politics

Tech

General

Kevin O'Leary Torpedoes Trump's TikTok Deal Claim: 'We Don't Have A Seller'

If building wealth feels impossible, you're not alone — especially when you're just getting started. But according to late billionaire investor Charlie Munger, the key to getting rich isn't chasing millions or betting big on the next hot stock. It starts with a single, stubborn goal: get your hands on $100,000.
"I don't care what you have to do," Munger said back in the late 1990s. "If it means walking everywhere and not eating anything that wasn't purchased with a coupon, find a way to get your hands on $100,000."
He admitted that it's a brutal milestone. "The first $100,000 is a b&#x2A;tch, but you gotta do it," he said.
Don't Miss:
<ul class="wp-block-list">
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
To be clear, Munger wasn't talking about letting it sit in a checking account. He meant invested — put to work, compounding over time. Once you cross that threshold, he argued, wealth starts to build on itself. You don't need to hustle harder—you just need to be consistent, stay invested, and let the math do the heavy lifting.
And he wasn't wrong.
For someone earning an average income and managing to invest $10,000 per year, it could take close to eight years to hit that six-figure target if they're earning around 7% annually—roughly in line with long-term stock market returns. But after that, something shifts. With $100,000 invested and compounding, earning just 7% per year could turn into $200,000 in just over 10 years. Stay the course, and it could snowball to more than $1.4 million in 40 years.
That's the power Munger was talking about. Not magic. Just compound interest—amplified by time, discipline, and not losing your nerve.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
It's also psychological. Many <a href="https://youtu.be/U1mcmB4oQU0?si=sPi-By0iu3o5DoQg">financial experts agree the $100K mark</a> is not just the hardest financially, but mentally. It's the point where habits are formed, consistency gets tested, and lifestyle choices often have to be reconsidered. Hitting that first benchmark means cutting back, avoiding shortcuts, and often working harder for longer than feels fair. And that's exactly why Munger emphasized it.
The challenge is even steeper today. <a href="https://data.bls.gov/cgi-bin/cpicalc.pl?cost1=100,000.00&amp;year1=199801&amp;year2=202505">Adjusted for inflation</a>, $100,000 in the late '90s would be closer to $190,000 today. But the principle still holds. Getting to your first six figures is a financial boot camp—one that trains you for everything that follows.
Munger didn't just toss out this advice casually. He lived it. Alongside Warren Buffett, he built one of the most successful investing empires in American history—by focusing on fundamentals, patience, and math over hype and shortcuts.
So is Munger right? Absolutely. Whether it takes five years or fifteen, getting that first $100,000 invested is still the hardest — and most important — step to building real wealth. The rest may not be easy, but it's a lot smoother once the compounding kicks in.
See Also: <a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
And as Munger said, no matter how hard it is: "You gotta do it."
For those still trying to hit that milestone, there are a few consistent patterns seen among people who make it happen. While everyone's situation is different, some tend to build toward that first $100,000 through a mix of high savings rates, side income, or long-term investing in low-fee index funds that have historically mirrored the S&amp;P 500's average return of around 7% annually. Others explore <a href="https://www.benzinga.com/personal-finance/25/02/43887869/80-year-old-with-250000-nest-egg-asks-dave-ramsey-where-to-keep-it-safe-he-suggests-this-investment-for-peace-but-it-doesnt-pay-much">interest-bearing accounts like CDs</a>, which at times have offered yields between 4% and 5%, though they lack the compounding growth potential of equities over longer time horizons.
Munger himself famously said the Munger <a href="https://www.benzinga.com/personal-finance/management/25/06/45984919/charlie-munger-only-owned-3-stocks-and-called-diversification-a-strategy-for-people-who-know-nothing-am-i-securely-rich-damn-right-i-am">family only held about three stocks</a>—emphasizing concentration, not chasing dozens of investments. His philosophy was less about outsmarting the market and more about sticking to what you understand and holding firm.
In the end, whether it's slow, boring, or brutally hard, the <a href="https://www.benzinga.com/personal-finance/25/02/43539942/are-you-rich-heres-what-americans-think-you-need-to-be-considered-wealthy-2">$100,000 goal isn't just about the number</a>—it's about proving you can do hard things consistently. And once that's done, as Munger promised, it gets better.
Read Next: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence.&nbsp;</a>
Image: Shutterstock

Personal Finance

Charlie Munger Said If You Want To Get Rich, The Secret Is To 'Get Your Hands On $100,000' —It's The Hardest Milestone, But 'You Gotta Do It'

American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) has outperformed the market over the past 20 years by 3.93% on an annualized basis producing an average annual return of 12.36%. Currently, American Tower has a market capitalization of $103.32 billion. 
Buying $100 In AMT: If an investor had bought $100 of AMT stock 20 years ago, it would be worth $1,030.35 today based on a price of $220.70 for AMT at the time of writing.
<h3>American Tower's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752015618_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning American Tower Stock In The Last 20 Years

Essential Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>) has outperformed the market over the past 5 years by 1.97% on an annualized basis producing an average annual return of 16.5%. Currently, Essential Properties has a market capitalization of $6.16 billion. 
Buying $100 In EPRT: If an investor had bought $100 of EPRT stock 5 years ago, it would be worth $211.67 today based on a price of $31.20 for EPRT at the time of writing.
<h3>Essential Properties's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752014716_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EPRT

Here's How Much $100 Invested In Essential Properties 5 Years Ago Would Be Worth Today

A report from Hunterbrook Media published on Tuesday presents a detailed investigation that reveals Western-manufactured microelectronic components are being integrated into Russian military aircraft and weapons used in precision attacks on civilian<a href="https://www.benzinga.com/news/politics/25/07/46289306/anduril-ceo-palmer-luckey-says-thank-you-as-trump-resumes-ukraine-arms-shipments"> targets in Ukraine.&nbsp;</a>
What To Know: The investigation by the Independent Anti-Corruption Commission (NAKO) and the International Partnership for Human Rights (IPHR), with <a href="https://hntrbrk.com/jet-report/">support from</a> Hunterbrook Media, traced over 1,100 microelectronic components from 141 Western companies embedded in Russian Su-34 and Su-35S fighter jets and weapons central to Moscow's precision bombing campaigns.&nbsp;
Read Next: <a href="https://www.benzinga.com/markets/tech/25/07/46298744/solar-stocks-sink-trump-slashes-green-tax-breaks?utm_source=articleShare">Solar Stocks Sink: Trump Slashes Green Tax Breaks</a>&nbsp;
The components were from manufacturers across 11 countries, with the majority coming from U.S. chipmakers including Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Analog Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>), On Semiconductor Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) and Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>). 
The report reveals that despite international sanctions, a complex global supply chain continues to funnel Western technology into Russia.&nbsp;
The investigation analyzed over 180,000 customs shipment records from 2023, revealing a trade worth approximately $805 million in microelectronic goods.&nbsp;
Countries like Serbia play a key role as intermediaries, with sanctioned goods routed through places like Hong Kong and Sri Lanka before ending up in Russia.&nbsp;
"Russia mastered the art of circumventing sanctions," said Anastasiya Donets, head of the Ukrainian legal team at IPHR.&nbsp;
"They are still getting Western tech in Russian weapons that are killing Ukrainians every day," Donets added.&nbsp;
What Else: Several U.S. semiconductor firms — including Analog Devices, Intel, Texas Instruments and AMD — faced scrutiny during a 2024 <a href="https://www.hsgac.senate.gov/subcommittees/investigations/hearings/the-us-companies-technology-fueling-the-russian-war-machine/">hearing</a> of the U.S. Senate Permanent Subcommittee on Investigations, titled &#8220;The U.S. Companies' Technology Fueling the Russian War Machine.&#8221;
The hearing revealed that components from the companies were discovered in the Russian Kh-101 cruise missile responsible for the attack on Ukraine's largest children's hospital in 2024.
Senators identified critical shortcomings in the export control and compliance systems of the firms, including weak or delayed responses to external warnings about potential misuse and the absence of regular, systematic audits to detect and prevent diversion.&nbsp;
Donets said that the companies with components used in Russia's attacks have "not only legal, but also a moral obligation" to prevent their technology from being used to kill innocent people. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46284237/sofi-ready-to-capture-the-opportunity-as-trumps-big-beautiful-plan-restricts-federal-student-loans?utm_source=articleShare">SoFi Ready To &#8216;Capture The Opportunity&#8217; As Trump&#8217;s &#8216;Big, Beautiful&#8217; Plan Restricts Federal Student Loans</a></li>
</ul>
Photo: Shutterstock

Global

Movers

INTC

US Tech, Russian Weapons: How Our Chips Power Putin's War

College? For many in Gen Z, that's starting to sound like a bad investment.&nbsp;
<a href="https://www.benzinga.com/news/earnings/earnings-beats/25/05/45183830/is-college-still-worth-it-gen-z-and-millennials-are-losing-faith-as-ai-disrupts-the-job-market">Why rack up student debt</a> when you can make six figures welding, plumbing, or wiring up a house? That's been the thinking behind the surge in trade-school enrollment — and the so-called "toolbelt generation" is proud to be hands-on. But according to recent data, some of the very careers drawing young workers away from traditional degrees are also posting some of the highest unemployment rates.
According to a <a href="https://www.creditkarma.com/about/commentary/gen-z-drives-a-resurgence-in-blue-collar-work">2024 Harris Poll for Intuit Credit Karma</a>, 78% of Americans believe more young people are choosing trade jobs over college. And they're not wrong. Data from the <a href="https://www.studentclearinghouse.org/nscblog/vocational-focused-public-2-years-lead-enrollment-rise/">National Student Clearinghouse</a> shows trade program enrollment is booming, especially in construction and repair.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
On TikTok and Reddit, you'll find Gen Zers touting the benefits of working with their hands: faster paydays, no student loans, and a belief that jobs like <a href="https://www.benzinga.com/tech/25/05/45613320/ai-is-gutting-entry-level-jobs-and-gen-z-is-paying-the-price-warns-linkedins-aneesh-raman">welding and plumbing are "AI-proof."</a>
But a new <a href="https://wallethub.com/edu/best-entry-level-jobs/3716">study from WalletHub</a> throws a wrench in that narrative. Among entry-level roles, building inspectors, electricians, and plumbers are tied for the highest unemployment rate: 7.2%. That's more than three times the unemployment rate for entry-level financial analysts (2.3%), and more than double the rate for graphic designers (3.3%).
Why the mismatch? For one, these roles are often tied to broader economic cycles. It makes sense when you think about it — jobs like plumbing, electrical work, and inspections often depend on new construction and renovations. When building slows down, so does demand. Factor in seasonal shifts and unpredictable project timelines, and some tradespeople may find themselves hustling for steady work.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
And it's not just about job security. A <a href="https://www.careerexplorer.com/careers/electrician/satisfaction/#:~:text=Electricians%20are%20below%20average%20when,the%20bottom%2029%25%20of%20careers.">survey by CareerExplorer</a> found that some trade roles are struggling in other areas too — especially when it comes to satisfaction. Electricians, for instance, rated their career happiness at just three out of five stars, landing in the bottom 29% of all professions. The work is physically demanding, often involves long hours, and in some cases, faces pressure from automation and prefabricated systems.
That doesn't mean all trade paths are risky. Specialized roles — like geotechnical engineers, mining technicians, and drilling specialists — showed far stronger long-term employment and pay stability. It's the generalist roles, especially those dependent on cyclical construction markets, where new workers may hit snags.
Still, for many Gen Zers, the appeal of avoiding $30,000 in student loans and landing a $60,000–$100,000 paycheck early in life is hard to ignore. And with <a href="https://www.benzinga.com/personal-finance/25/03/44481583/bill-gates-thinks-you-might-only-work-2-3-days-a-week-thanks-to-ai-but-also-says-legitimately-people-are-like-wow-this-is-a-bit-scary">AI threatening to upend traditional office jobs</a>, trades still feel like a safer, more grounded choice.
But the data serves as a reminder: not all six-figure trade jobs are built the same. Some may come with more downtime than expected — even if they look solid on paper.
So yes, Gen Z might be trading college degrees for toolboxes. Just don't assume that every wrench comes with job security.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence. </a></li>
</ul>
Image: Shutterstock

Gen Z Is Skipping College for 6-Figure Trade Jobs Like Welding And Plumbing — But These Careers Now Have The Highest Unemployment Rate

Kinross Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) has outperformed the market over the past 10 years by 10.71% on an annualized basis producing an average annual return of 22.12%. Currently, Kinross Gold has a market capitalization of $18.68 billion. 
Buying $1000 In KGC: If an investor had bought $1000 of KGC stock 10 years ago, it would be worth $7,409.76 today based on a price of $15.23 for KGC at the time of writing.
<h3>Kinross Gold's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752013812_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Kinross Gold 10 Years Ago Would Be Worth This Much Today

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) recently reported a 13.5% year-over-year decline fo<a href="https://www.benzinga.com/trading-ideas/movers/25/07/46221375/tesla-stock-jumps-on-strong-q2-deliveries">r second-quarter vehicle deliveries.</a> A new report showed the impact the Chinese market may have played in the decline.
What Happened: Tesla has struggled with demand in many parts of the world in 2025 with <a href="https://www.benzinga.com/25/04/44937440/tesla-q1-earnings-highlights-revenue-miss-eps-miss-tariff-landscape-and-changing-political-sentiment-cloud-guidance">first-quarter deliveries</a> also down year-over-year.
Data from the China Passenger Car Association showed that Tesla deliveries in the second quarter were down 4.3% quarter-over-quarter and down 11.7% year-over-year. The company delivered 128,803 vehicles in China during the second quarter according to the data, reported by <a href="https://electrek.co/2025/07/08/tesla-tsla-sales-decline-china-despite-model-y-refresh-record-discounts/">Electrek</a>.
The company initially said the Model Y refresh and discounts would help boost demand in China in the second quarter. But, a sales decline happened even with the Model Y refresh and all variants of the top-selling electric vehicle available.
Read Also: <a href="https://www.benzinga.com/news/politics/25/07/46300946/musk-vs-trump-soap-opera-must-end-tesla-analyst-shares-3-key-steps">Musk Vs. Trump &#8216;Soap Opera Must End&#8217;: Tesla Analyst Shares 3 Key Steps</a>
Why It's Important: China is one of the largest electric vehicle markets in the world and a major source of deliveries for Tesla. While Tesla faces competition from other companies in the region, recent data showed that it could be struggling even greater than originally feared.
The data also showed that Tesla&#8217;s claims that the Model Y refresh and discounts would boost second-quarter deliveries in the region did not end up happening.
According to the report, Tesla was offering 0% financing on the Model 3 and Model Y in China during parts of the second quarter, marking record discounts.
While Tesla is facing continued pressure over boycotts and brand damage in Europe and the U.S., the report shows that in China it could be competition such as Xpeng, Xiaomi and others that are hurting demand for Tesla vehicles with EVs that are priced less than the Model Y.
TSLA Price Action: Tesla stock closed Tuesday up 1.32% Tuesday to $297.81 versus a 52-week trading range of $182 to $488.54. Tesla stock is down 21.5% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46303314/heres-how-much-1000-invested-in-tesla-stock-today-will-be-worth-if-cathie-woods-price-prediction-comes-true-in-2029-2">Here&#8217;s How Much $1,000 Invested In Tesla Stock Today Will Be Worth If Cathie Wood&#8217;s Price Prediction Comes True In 2029</a></li>
</ul>
Photo: Model, courtesy Tesla Inc.

Short Ideas

TSLA

Tesla Was Ready For Q2 China Comeback — But It Didn't Happen

Firan Technology Gr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FTG#TSX">FTG</a>) reported quarterly earnings of $0.14 per share. This is a 27.27 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $48.73 million which beat the analyst consensus estimate of $47.87 million by 1.79 percent. This is a 25.63 percent increase over sales of $38.79 million the same period last year.

Earnings

TSX:FTG

Firan Technology Gr Q2 EPS $0.14 Up From $0.11 YoY, Sales $48.73M Beat $47.87M Estimate

In the last three months, 18 analysts have published ratings on Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">9</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $88.72, along with a high estimate of $115.00 and a low estimate of $70.00. A 6.72% drop is evident in the current average compared to the previous average price target of $95.11. 
<img src="https://www.benzinga.com/files/images/story/2025/1752012061_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Coherent among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$92.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Tim Savageaux</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$92.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$83.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$95.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$74.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$86.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Mark Miller</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$95.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$95.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$85.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$70.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$136.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coherent. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Coherent compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Coherent's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Coherent's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/COHR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Coherent analyst ratings.</a>
<h2>Delving into Coherent's Background</h2>
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
<h3>Key Indicators: Coherent's Financial Health</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Coherent's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 23.91%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Coherent's net margin excels beyond industry benchmarks, reaching -1.13%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Coherent's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.32%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.12%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 0.74, Coherent faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

COHR

Breaking Down Coherent: 18 Analysts Share Their Views

Ratings for SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $16.08, a high estimate of $20.00, and a low estimate of $12.00. Marking an increase of 12.84%, the current average surpasses the previous average price target of $14.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1752012050_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive SoFi Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Terry Ma</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$18.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Matthew Coad</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Hold</td>
<td>$14.00</td>
<td>-</td>
</tr>
<tr>
<td>Terry Ma</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$12.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Tim Chiodo</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$15.50</td>
<td>$14.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Announces</td>
<td>Market Outperform</td>
<td>$17.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to SoFi Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of SoFi Technologies compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of SoFi Technologies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into SoFi Technologies's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SOFI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on SoFi Technologies analyst ratings.</a>
<h2>About SoFi Technologies</h2>
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
<h3>Financial Insights: SoFi Technologies</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3M period, SoFi Technologies showcased positive performance, achieving a revenue growth rate of 31.74% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 9.21%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): SoFi Technologies's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.08%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.19%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.47, SoFi Technologies adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SOFI

What Analysts Are Saying About SoFi Technologies Stock

During the last three months, 14 analysts shared their evaluations of Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $70.0, a high estimate of $77.00, and a low estimate of $63.00. This upward trend is apparent, with the current average reflecting a 2.01% increase from the previous average price target of $68.62.
<img src="https://www.benzinga.com/files/images/story/2025/1752012040_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Cisco Systems by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon Nispel</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$77.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Niknam</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$73.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Amit Daryanani</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$72.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$64.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$71.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$67.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$66.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$73.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$74.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Aaron Rakers</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Amit Daryanani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$67.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$63.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$68.00</td>
<td>$73.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Cisco Systems. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Cisco Systems compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Cisco Systems's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Cisco Systems's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CSCO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cisco Systems analyst ratings.</a>
<h2>Discovering Cisco Systems: A Closer Look</h2>
Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff—25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.
<h3>Cisco Systems's Economic Impact: An Analysis</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Over the 3M period, Cisco Systems showcased positive performance, achieving a revenue growth rate of 11.39% as of 30 April, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Cisco Systems's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 17.61%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Cisco Systems's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.45% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Cisco Systems's ROA excels beyond industry benchmarks, reaching 2.07%. This signifies efficient management of assets and strong financial health.
Debt Management: Cisco Systems's debt-to-equity ratio is below the industry average at 0.64, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CSCO

What 14 Analyst Ratings Have To Say About Cisco Systems

6 analysts have shared their evaluations of Flowserve (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLS#NYSE">FLS</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $57.17, with a high estimate of $70.00 and a low estimate of $50.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.04%. 
<img src="https://www.benzinga.com/files/images/story/2025/1752012032_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Flowserve among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$53.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$56.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$50.00</td>
<td>$77.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Flowserve. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Flowserve compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Flowserve's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Flowserve's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FLS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Flowserve analyst ratings.</a>
<h2>Delving into Flowserve's Background</h2>
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.
<h3>Breaking Down Flowserve's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Flowserve displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 5.25%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Flowserve's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 6.46%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Flowserve's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.62%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Flowserve's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.35%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.81, caution is advised due to increased financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

6 Analysts Assess Flowserve: What You Need To Know

In the latest quarter, 6 analysts provided ratings for Hologic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>), showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $67.67, with a high estimate of $71.00 and a low estimate of $62.00. This current average has decreased by 8.96% from the previous average price target of $74.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1752012023_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Hologic's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$68.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Mason Carrico</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Tejas Savant</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$70.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Andrew Cooper</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$71.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$62.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Hologic. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hologic compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Hologic's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Hologic's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HOLX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Hologic analyst ratings.</a>
<h2>Delving into Hologic's Background</h2>
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
<h3>A Deep Dive into Hologic's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3M period, Hologic faced challenges, resulting in a decline of approximately -1.23% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Hologic's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -1.73%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Hologic's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -0.37%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Hologic's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.2%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Hologic's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.55.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOLX

Breaking Down Hologic: 6 Analysts Share Their Views

In the current market session, ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) stock price is at $1022.98, after a 1.16% drop. However, over the past month, the company's stock went up by 1.31%, and in the past year, by 37.65%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1752012018_0.png" alt="Past Year Chart" />

<h3>How Does ServiceNow P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
ServiceNow has a better P/E ratio of 140.44 than the aggregate P/E ratio of 95.67 of the Software industry. Ideally, one might believe that ServiceNow Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1752012018_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: ServiceNow

Press Releases

Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents

Moleculin Announces World Health Organization Approval of "naxtarubicin" as International Non-Proprietary Name for Annamycin

Moleculin to Report First Quarter 2025 Financial Results on May 13, 2025 and Host Conference Call and Webcast

Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial

Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107)

Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107)

Moleculin Participates in Virtual Investor "What This Means" Segment

Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML

Moleculin Announces $5.9 Million Public Offering

MBRX

AIM ImmunoTech

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

180 Life Sciences

Bone Biologics

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

GT Biopharma

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Mainz Biomed

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Sunshine Biopharma

SILO Pharma

Silexion Therapeutics Corp - Ordinary Shares

Comments

Moleculin Biotech

Moleculin Biotech (MBRX) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO